QL
JAZZ icon

Quarry LP’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quarry LP’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17K Buy
+9
New +$1.97K ﹤0.01% 1588
2025
Q4 		– Sell
-2,125
Closed -$280K – 2373
2025
Q3 		$280K Sell
2,125
-1,475
-41% -$177K 0.06% 274
2025
Q2 		$382K Buy
3,600
+2,400
+200% +$261K 0.08% 217
2025
Q1 		$149K Sell
1,200
-500
-29% -$65.2K 0.03% 374
2024
Q4 		$209K Buy
1,700
+100
+6% +$11.8K 0.03% 240
2024
Q3 		$178K Buy
+1,600
New +$175K 0.04% 265

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Quarry LP's JAZZ Position: Q2 2026 in Review

Quarry LP opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 9 shares worth $2.17K. The stake represents ﹤0.01% of the portfolio and ranks #1588 among its holdings. This is a return to the name: Quarry LP previously reported a position in JAZZ as recently as Q3 2025.

Quarry LP first reported a position in JAZZ in Q3 2024 and has held it in 6 quarters since. The position peaked at $382K in Q2 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Quarry LP held 9 shares of Jazz Pharmaceuticals worth $2.17K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1588 holding.
  • Quarry LP first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Quarry LP's Jazz Pharmaceuticals position peaked at $382K in Q2 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.